{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:53:53Z","timestamp":1777337633650,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["8430044117"],"award-info":[{"award-number":["8430044117"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zambon","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current guidelines recommend that every person with Parkinson\u2019s disease (PD) should have access to Parkinson\u2019s disease nurse specialist (PDNS) care. However, there is little scientific evidence of the cost-effectiveness of PDNS care. This hampers wider implementation, creates unequal access to care, and possibly leads to avoidable disability and costs. Therefore, we aim to study the (cost-)effectiveness of specialized nursing care provided by a PDNS compared with usual care (without PDNS) for people with PD in all disease stages. To gain more insight into the deployed interventions and their effects, a preplanned subgroup analysis will be performed on the basis of disease duration (diagnosis &lt;\u20095, 5\u201310, or\u2009&gt;\u200910\u2009years ago).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We will perform an 18-month, single-blind, randomized controlled clinical trial in eight community hospitals in the Netherlands. A total of 240 people with PD who have not been treated by a PDNS over the past 2 years will be included, independent of disease severity or duration. In each hospital, 30 patients will randomly be allocated in a 1:1 ratio to receive either care by a PDNS (who works according to a recent guideline on PDNS care) or usual care. We will use two co-primary outcomes: quality of life (measured with the Parkinson\u2019s Disease Questionnaire-39) and motor symptoms (measured with the Movement Disorders Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale part III). Secondary outcomes include nonmotor symptoms, health-related quality of life, experienced quality of care, self-management, medication adherence, caregiver burden, and coping skills. Data will be collected after 12\u2009months and 18\u2009months by a blinded researcher. A healthcare utilization and productivity loss questionnaire will be completed every 3\u2009months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The results of this trial will have an immediate impact on the current care of people with PD. We hypothesize that by offering more patients access to PDNS care, quality of life will increase. We also expect healthcare costs to remain equal because increases in direct medical costs (funding additional nurses) will be offset by a reduced number of consultations with the general practitioner and neurologist. If these outcomes are reached, wide implementation of PDNS care will be warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03830190\">NCT03830190<\/jats:ext-link>\n                      . Registered February 5, 2019 (retrospectively registered).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-019-3926-y","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T07:02:37Z","timestamp":1579071757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The cost-effectiveness of specialized nursing interventions for people with Parkinson\u2019s disease: the NICE-PD study protocol for a randomized controlled clinical trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-6681","authenticated-orcid":false,"given":"Danique L. M.","family":"Radder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herma H.","family":"Lennaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thies","family":"van Asseldonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cath\u00e9rine C. S.","family":"Delnooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob H.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marten","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"key":"3926_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/S0140-6736(02)08520-3","volume":"359","author":"O Rascol","year":"2002","unstructured":"Rascol O, Goetz C, Koller W, Poewe W, Sampaio C. Treatment interventions for Parkinson\u2019s disease: an evidence based assessment. Lancet. 2002;359:1589\u201398.","journal-title":"Lancet."},{"key":"3926_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1353-8020(97)00021-7","volume":"3","author":"KE Lyons","year":"1997","unstructured":"Lyons KE, Pahwa R, Troster AI, Koller WC. A comparison of Parkinson\u2019s disease symptoms and self-reported functioning and well being. Parkinsonism Relat Disord. 1997;3:207\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"3926_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.parkreldis.2013.06.005","volume":"19","author":"FJ Carod-Artal","year":"2013","unstructured":"Carod-Artal FJ, Mesquita HM, Ziomkowski S, Martinez-Martin P. Burden and health-related quality of life among caregivers of Brazilian Parkinson\u2019s disease patients. Parkinsonism Relat Disord. 2013;19:943\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"3926_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 3","key":"3926_CR5","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1002\/mds.23884","volume":"26","author":"K Seppi","year":"2011","unstructured":"Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson\u2019s disease. Mov Disord. 2011;26(Suppl 3):S42\u201380.","journal-title":"Mov Disord"},{"key":"3926_CR6","doi-asserted-by":"publisher","first-page":"g6258","DOI":"10.1136\/bmj.g6258","volume":"349","author":"CG Goetz","year":"2014","unstructured":"Goetz CG, Pal G. Initial management of Parkinson\u2019s disease. BMJ. 2014;349:g6258.","journal-title":"BMJ."},{"key":"3926_CR7","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/jan.13335","volume":"73","author":"MV Navarta-S\u00e1nchez","year":"2017","unstructured":"Navarta-S\u00e1nchez MV, Caparr\u00f3s N, Riverol Fern\u00e1ndez M, D\u00edaz De Cerio Ayesa S, Urs\u00faa Sesma ME, Portillo MC. Core elements to understand and improve coping with Parkinson\u2019s disease in patients and family carers: a focus group study. J Adv Nurs. 2017;73:2609\u201321.","journal-title":"J Adv Nurs"},{"key":"3926_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0269216310385604","volume":"25","author":"D McLaughlin","year":"2011","unstructured":"McLaughlin D, Hasson F, Kernohan WG, Waldron M, McLaughlin M, Cochrane B, et al. Living and coping with Parkinson\u2019s disease: perceptions of informal carers. Palliat Med. 2011;25:177\u201382.","journal-title":"Palliat Med"},{"key":"3926_CR9","first-page":"CD001271","volume":"7","author":"M Laurant","year":"2018","unstructured":"Laurant M, van der Biezen M, Wijers N, Watananirun K, Kontopantelis E, van Vught AJ. Nurses as substitutes for doctors in primary care. Cochrane Database Syst Rev. 2018;7:CD001271.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7 Suppl 3","key":"3926_CR10","first-page":"S21","volume":"52","author":"DG MacMahon","year":"1999","unstructured":"MacMahon DG. Parkinson\u2019s disease nurse specialists: an important role in disease management. Neurology. 1999;52(7 Suppl 3):S21\u20135.","journal-title":"Neurology"},{"key":"3926_CR11","first-page":"749","volume":"7","author":"H Lennaerts","year":"2017","unstructured":"Lennaerts H, Groot M, Rood B, Gilissen K, Tulp H, van Wensen E, et al. A guideline for Parkinson\u2019s disease nurse specialists, with recommendations for clinical practice. J Park Dis. 2017;7:749\u201354.","journal-title":"J Park Dis"},{"key":"3926_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1155\/1994\/916963","volume":"7","author":"M Jahanshahi","year":"1994","unstructured":"Jahanshahi M, Brown RG, Whitehouse C, Quinn N, Marsden CD. Contact with a nurse practitioner: a short-term evaluation study in Parkinson\u2019s disease and dystonia. Behav Neurol. 1994;7:189\u201396.","journal-title":"Behav Neurol"},{"key":"3926_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0020-7489(00)00013-4","volume":"37","author":"H Reynolds","year":"2000","unstructured":"Reynolds H, Wilson-Barnett J, Richardson G. Evaluation of the role of the Parkinson\u2019s disease nurse specialist. Int J Nurs Stud. 2000;37:337\u201349.","journal-title":"Int J Nurs Stud"},{"key":"3926_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/bmj.324.7345.1072","volume":"324","author":"B Jarman","year":"2002","unstructured":"Jarman B, Hurwitz B, Cook A, Bajekal M, Lee A. Effects of community based nurses specialising in Parkinson\u2019s disease on health outcome and costs: randomised controlled trial. BMJ. 2002;324:1072\u20135.","journal-title":"BMJ"},{"key":"3926_CR15","doi-asserted-by":"publisher","first-page":"e016405","DOI":"10.1136\/bmjopen-2017-016405","volume":"7","author":"MJC Timmermans","year":"2017","unstructured":"Timmermans MJC, van den Brink GT, van Vught AJAH, Adang E, van Berlo CLH, Boxtel KV, et al. The involvement of physician assistants in inpatient care in hospitals in the Netherlands: a cost-effectiveness analysis. BMJ Open. 2017;7:e016405.","journal-title":"BMJ Open"},{"key":"3926_CR16","doi-asserted-by":"publisher","first-page":"e007167","DOI":"10.1136\/bmjopen-2014-007167","volume":"5","author":"R Martin-Misener","year":"2015","unstructured":"Martin-Misener R, Harbman P, Donald F, Reid K, Kilpatrick K, Carter N, et al. Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review. BMJ Open. 2015;5:e007167.","journal-title":"BMJ Open"},{"issue":"3","key":"3926_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"key":"3926_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"3926_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1017\/S1355617717000522","volume":"23","author":"O Bezdicek","year":"2017","unstructured":"Bezdicek O, R\u016f\u017ei\u010dka F, Fendrych Mazancova A, Roth J, Du\u0161ek P, Mueller K, et al. Frontal Assessment Battery in Parkinson\u2019s disease: validity and morphological correlates. J Int Neuropsychol Soc. 2017;23:675\u201384.","journal-title":"J Int Neuropsychol Soc"},{"key":"3926_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.nedt.2018.09.017","volume":"71","author":"J Tornwall","year":"2018","unstructured":"Tornwall J. Peer assessment practices in nurse education: an integrative review. Nurse Educ Today. 2018;71:266\u201375.","journal-title":"Nurse Educ Today"},{"key":"3926_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12968\/bjon.2001.10.2.5394","volume":"10","author":"N Gopee","year":"2001","unstructured":"Gopee N. The role of peer assessment and peer review in nursing. Br J Nurs. 2001;10:115\u201321.","journal-title":"Br J Nurs"},{"key":"3926_CR22","unstructured":"CBO. Zorgmodule Zelfmanagement 1.0. Utrecht: CBO; 2014. https:\/\/zelfzorgondersteund-instrumentenkiezer.nl\/wp-content\/uploads\/2016\/02\/Zorgmodule_Zelfmanagement_1.0.pdf. Accessed 29 Dec 2019."},{"key":"3926_CR23","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1111\/jocn.14247","volume":"27","author":"R Feo","year":"2018","unstructured":"Feo R, Conroy T, Jangland E, Muntlin Athlin \u00c5, Brovall M, Parr J, et al. Towards a standardised definition for fundamental care: a modified Delphi study. J Clin Nurs. 2018;27:2285\u201399.","journal-title":"J Clin Nurs"},{"issue":"Suppl 1","key":"3926_CR24","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1007\/PL00007730","volume":"245","author":"V Peto","year":"1998","unstructured":"Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson\u2019s disease quality of life questionnaire and its associated measures. J Neurol. 1998;245(Suppl 1):S10\u20134.","journal-title":"J Neurol"},{"key":"3926_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.21198","volume":"22","author":"CG Goetz","year":"2007","unstructured":"Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord. 2007;22:41\u20137.","journal-title":"Mov Disord"},{"key":"3926_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S. The Timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"3926_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69\u201377.","journal-title":"J Psychosom Res"},{"key":"3926_CR28","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord. 2004;19:1306\u201312.","journal-title":"Mov Disord"},{"key":"3926_CR29","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/sleep\/26.8.1049","volume":"26","author":"J Marinus","year":"2003","unstructured":"Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep. 2003;26:1049\u201354.","journal-title":"Sleep."},{"key":"3926_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. EuroQol \u2013 a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"3926_CR31","doi-asserted-by":"crossref","unstructured":"Ikkersheim DE, Koolman X. Dutch healthcare reform: did it result in better patient experiences in hospitals? A comparison of the consumer quality index over time. BMC Health Serv Res. 2012;12:76. https:\/\/www.zorginstituutnederland.nl\/publicaties\/publicatie\/2016\/02\/29\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg. Accessed 29 Dec 2019.","DOI":"10.1186\/1472-6963-12-76"},{"key":"3926_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/1471-2458-12-577","volume":"12","author":"J Rademakers","year":"2012","unstructured":"Rademakers J, Nijman J, van der Hoek L, Heijmans M, Rijken M. Measuring patient activation in The Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13). BMC Public Health. 2012;12:577.","journal-title":"BMC Public Health"},{"key":"3926_CR33","doi-asserted-by":"publisher","first-page":"e0187139","DOI":"10.1371\/journal.pone.0187139","volume":"12","author":"SJ Moon","year":"2017","unstructured":"Moon SJ, Lee WY, Hwang JS, Hong YP, Morisky DE. Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS One. 2017;12:e0187139.","journal-title":"PLoS One"},{"key":"3926_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jpainsymman.2016.09.007","volume":"53","author":"P Hagell","year":"2017","unstructured":"Hagell P, Alvariza A, Westergren A, \u00c5restedt K. Assessment of burden among family caregivers of people with Parkinson\u2019s disease using the Zarit Burden Interview. J Pain Symptom Manag. 2017;53:272\u20138.","journal-title":"J Pain Symptom Manag"},{"key":"3926_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1477-7525-11-173","volume":"11","author":"RJ Hoefman","year":"2013","unstructured":"Hoefman RJ, van Exel J, Brouwer WB. Measuring the impact of caregiving on informal carers: a construct validation study of the CarerQol instrument. Health Qual Life Outcomes. 2013;11:173.","journal-title":"Health Qual Life Outcomes"},{"key":"3926_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.apmr.2013.11.010","volume":"95","author":"NS Tielemans","year":"2014","unstructured":"Tielemans NS, Visser-Meily JM, Schepers VP, Post MW, van Heugten CM. Proactive coping poststroke: psychometric properties of the Utrecht Proactive Coping Competence Scale. Arch Phys Med Rehabil. 2014;95:670\u20135.","journal-title":"Arch Phys Med Rehabil"},{"key":"3926_CR37","unstructured":"Institute for Medical Technology Assessment (iMTA). Questionnaires for the measurement of costs in economic evaluations. https:\/\/www.imta.nl\/questionnaires\/. Accessed 9 Nov 2019."},{"key":"3926_CR38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jval.2015.05.009","volume":"18","author":"C Bouwmans","year":"2015","unstructured":"Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van Roijen L. The iMTA Productivity Cost Questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18:753\u20138.","journal-title":"Value Health"},{"key":"3926_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.parkreldis.2014.03.019","volume":"20","author":"D Charles","year":"2014","unstructured":"Charles D, Konrad PE, Neimat JS, Molinari AL, Tramontana MG, Finder SG, et al. Subthalamic nucleus deep brain stimulation in early stage Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20:731\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"3926_CR40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/ana.21596","volume":"65","author":"MS Okun","year":"2009","unstructured":"Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F, et al. Cognition and mood in Parkinson\u2019s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009;65:586\u201395.","journal-title":"Ann Neurol"},{"key":"3926_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S. Adjusting for multiple testing\u2014when and how? J Clin Epidemiol. 2001;54:343\u20139.","journal-title":"J Clin Epidemiol"},{"key":"3926_CR42","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WM Schuepbach","year":"2013","unstructured":"Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson\u2019s disease with early motor complications. N Engl J Med. 2013;368:610\u201322.","journal-title":"N Engl J Med"},{"key":"3926_CR43","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/mds.25194","volume":"28","author":"MA van der Marck","year":"2013","unstructured":"van der Marck MA, Bloem BR, Borm GF, Overeem S, Munneke M, Guttman M. Effectiveness of multidisciplinary care for Parkinson\u2019s disease: a randomized, controlled trial. Mov Disord. 2013;28:605\u201311.","journal-title":"Mov Disord"},{"key":"3926_CR44","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/mds.10591","volume":"18","author":"CG Goetz","year":"2003","unstructured":"Goetz CG, LeWitt PA, Weidenman M. Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program. Mov Disord. 2003;18:1455\u20138.","journal-title":"Mov Disord"},{"key":"3926_CR45","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/mds.23834","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, et al. Health-related quality-of-life scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2011;26:2371\u201380.","journal-title":"Mov Disord"},{"key":"3926_CR46","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u201370.","journal-title":"Mov Disord"},{"key":"3926_CR47","unstructured":"Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Zorginstituut Nederland; 2016. https:\/\/www.zorginstituutnederland.nl\/publicaties\/ publicatie\/2016\/02\/29\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg. Accessed 9 Nov 2019."},{"key":"3926_CR48","unstructured":"ClinicalTrials.gov. Cost-effectiveness of nursing interventions for patients with PD (NICE-PD). 2019-02-05. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03830190. Accessed 9 Nov 2019."},{"key":"3926_CR49","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.","journal-title":"BMJ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3926-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T19:31:52Z","timestamp":1610566312000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3926-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3926"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3926-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.9338\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.9338\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study will be conducted in accordance with the good clinical practice guidelines promulgated by the International Conference on Harmonization, the principles of the Declaration of Helsinki, and the Medical Research Involving Human Subjects Act. The NICE-PD study protocol and communication materials have been approved by the local ethics committee (Commissie Mensgebonden Onderzoek Arnhem-Nijmegen; NL65468.091.18). The study is registered with the\n                      \n                      registry (identifier NCT03830190) [\n                      \n                      ]. The trial results will be reported according to the Consolidated Standards of Reporting Trials (CONSORT) 2010 guidelines [\n                      \n                      ].When a patient meets the inclusion criteria, informed consent will be obtained by the research team after the team explains the procedures and requirements of the study, how subjects\u2019 confidentiality will be maintained, and any potential hazards\/risks. Each patient will sign an informed consent form in person at the baseline visit before baseline assessment takes place. The researcher will sign the informed consent immediately after the patient has signed it. The researcher provides a copy of the signed informed consent form to each participant and keeps a copy in the participant\u2019s study file.When important changes are made to the study protocol (e.g., changes in eligibility criteria, outcomes, or statistical analyses), the principal investigator will notify relevant parties about these changes, and a copy of the revised protocol will be sent to these parties (e.g., the ethics committee, participating centers, and the clinical trial registry). Furthermore, the updated protocol will be included in the trial registry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BRB and MM were supported by a research grant from the Parkinson\u2019s Foundation and the Gatsby Foundation. DLMR, HHL, and NMdV were supported by a research grant from ZonMw (The Netherlands Organisation for Health Research and Development) and Zambon. HV, TvA, CCSD and RHH declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}